Cargando…
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases
Dramatic advancement has been made in recent decades to understand the basis of autoimmunity-mediated neurological diseases. These diseases create a strong influence on the central nervous system (CNS) and the peripheral nervous system (PNS), leading to various clinical manifestations and numerous s...
Autores principales: | Ashraf, Hajra, Solla, Paolo, Sechi, Leonardo Atonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504155/ https://www.ncbi.nlm.nih.gov/pubmed/36145298 http://dx.doi.org/10.3390/ph15091077 |
Ejemplares similares
-
Latent Potential of Multifunctional Selenium Nanoparticles in Neurological Diseases and Altered Gut Microbiota
por: Ashraf, Hajra, et al.
Publicado: (2023) -
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
por: Liu, Jinsha, et al.
Publicado: (2021) -
Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy
por: Hajra, A, et al.
Publicado: (2017) -
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases
por: Pan, Shing Yi, et al.
Publicado: (2020) -
Editorial: Opportunities and Challenges for Drug Discovery From Natural Products in Pharmacotherapy of Neurological Disorders
por: Jeandet, Philippe, et al.
Publicado: (2022)